News

STAT2d
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, to step down as company seeks a turnaround
Lars Fruergaard Jørgensen is stepping down as Novo Nordisk CEO, with the company citing its stock's recent struggles.
Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...
Novo CEO’s Shock Exit: Who Will Take Over Obesity Drug Giant?
Novo Nordisk A/S’s surprise decision to replace Chief Executive Officer Lars Fruergaard Jorgensen has triggered a race to ...
Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn
In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...
Novo Nordisk ousts CEO after falling behind in weight loss market
Pedersen and Stine Jacobsen COPENHAGEN (Reuters) - Wegovy-maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday ...
Novo CEO Was Blindsided on Call by Chairman Before His Departure
When Novo Nordisk A/S Chief Executive Officer Lars Fruergaard Jorgensen dialed into a Teams video call with Chairman Helge ...